Table 3.
Quality of life (QOL) comparison between baseline and completion of trial for pancreatic enzyme subgroup
| Baseline | Completion of trial | ||||
|---|---|---|---|---|---|
| QOL parameter | Mean | N | Mean | t | p Value |
| Dysphoria | 45.74±28.08 | 22 | 75.71±21.97 | −5.04 | 0.000 |
| Interference w/activity | 37.42±18.02 | 21 | 68.54±21.36 | −6.14 | 0.000 |
| Body image | 70.07±23.35 | 19 | 86.84±15.44 | −3.27 | 0.004 |
| Health worry | 64.68±16.65 | 21 | 82.94±13.30 | −4.55 | 0.000 |
| Food avoidance | 20.83±20.21 | 22 | 56.06±27.96 | −5.55 | 0.000 |
| Social reaction | 54.89±19.49 | 23 | 76.36±21.81 | −4.87 | 0.000 |
| Sexual | 73.21±33.14 | 21 | 85.12±26.70 | −2.25 | 0.036 |
| Relationships | 56.67±23.51 | 20 | 77.50±19.70 | −5.35 | 0.000 |
| Overall score | 46.11±15.35 | 14 | 77.10±15.82 | −5.49 | 0.000 |